This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

A short relevant text to discern each part.

No code assigned by the regultory authorities, use a short relevant text to discern each part.

A coded concept that defines the type of a medication.

Code for the part : no code assigned by the regultory authorities

No code but a short text depicting the part. For instance, white tablet for a proprietary named medication made of white tablets and blue tablets

No code but a text descripting the part.

No regulatory authority label but a text descripting the part. It is a short text, relevant enough to discern the different parts of the medication.

A short text, relevant enough to discern the different parts of the medication.

This is the only way for identifing the part to the medication. However it is not an absolute idenfication.

A code to indicate if the medication is in active use.

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

A coded concept defining if the medication is in active use.

No distinct manufacturer for each part of the medication

No distinct manufacturer for each part. Each part inherits the whole medication manufacturer.

Describes the form of the item. Powder; tablets; capsule.

This is the defined dose form of this part of the branded medication.

The dose form of the part is always defined and SHALL be provided.

Identifies a particular constituent of interest in the product.

For the active ingedients, the medication contains ALL the ingredients and ONLY the ingredients.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

The actual substance or sub-part of the part of the branded medication.

Most of the few multi-part branded medication have a single level of parts with no sub-parts. For instance, a white tablet and a bue tablet. The item[x].refeence(FrMedicationUcdPart) is intende to describe the very few more complex multipart branded medications.

Support of french multi-part branded medication identfied by a code UDC.

Specifies how much subtance of the item[x]:codeableConcept(snomedSubstance) or how many of the item[x]:refernce(FrMedciationUcdPart) there are in this FrMedicationUcdPart

The quantity of this ingredient defining the medication. For instance, 50 mg/mL defining the glucose quantity for the glucose 5% or 500 mg medicine and 30 mg respectively defining the paracetamol and the codeine quantity for the association paracetamol+codeine 500 mg+30 mg medicine.

This applies for the proprietary named medication involved in a MedicationDispense, MedicationAdministration or a MedicationUse.

WARNING: it is the batch number of the part. If it is not discerned for each part, it SHALL NOT be provided here but at the grouping level where it is defined, most often the UCD.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

A short relevant text to discern each part.

No code assigned by the regultory authorities, use a short relevant text to discern each part.

Code for the part : no code assigned by the regultory authorities

No code but a short text depicting the part. For instance, white tablet for a proprietary named medication made of white tablets and blue tablets

No code but a text descripting the part.

No regulatory authority label but a text descripting the part. It is a short text, relevant enough to discern the different parts of the medication.

A short text, relevant enough to discern the different parts of the medication.

This is the only way for identifing the part to the medication. However it is not an absolute idenfication.

No distinct manufacturer for each part of the medication

No distinct manufacturer for each part. Each part inherits the whole medication manufacturer.

This is the defined dose form of this part of the branded medication.

The dose form of the part is always defined and SHALL be provided.

For the active ingedients, the medication contains ALL the ingredients and ONLY the ingredients.

The actual substance or sub-part of the part of the branded medication.

Most of the few multi-part branded medication have a single level of parts with no sub-parts. For instance, a white tablet and a bue tablet. The item[x].refeence(FrMedicationUcdPart) is intende to describe the very few more complex multipart branded medications.

Support of french multi-part branded medication identfied by a code UDC.

Specifies how much subtance of the item[x]:codeableConcept(snomedSubstance) or how many of the item[x]:refernce(FrMedciationUcdPart) there are in this FrMedicationUcdPart

The quantity of this ingredient defining the medication. For instance, 50 mg/mL defining the glucose quantity for the glucose 5% or 500 mg medicine and 30 mg respectively defining the paracetamol and the codeine quantity for the association paracetamol+codeine 500 mg+30 mg medicine.

This applies for the proprietary named medication involved in a MedicationDispense, MedicationAdministration or a MedicationUse.

WARNING: it is the batch number of the part. If it is not discerned for each part, it SHALL NOT be provided here but at the grouping level where it is defined, most often the UCD.

This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.

The only time that a resource does not have an id is when it is being submitted to the server using a create operation.

The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.

The base language in which the resource is written.

Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute).

A human language.

A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety.

Contained resources do not have narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later.

These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, and nor can they have their own independent transaction scope.

This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags In their meta elements, but SHALL NOT have security labels.

May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Business identifier for this medication.

The serial number could be included as an identifier.

A short relevant text to discern each part.

No code assigned by the regultory authorities, use a short relevant text to discern each part.

A coded concept that defines the type of a medication.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Code for the part : no code assigned by the regultory authorities

No code but a short text depicting the part. For instance, white tablet for a proprietary named medication made of white tablets and blue tablets

No code but a text descripting the part.

No regulatory authority label but a text descripting the part. It is a short text, relevant enough to discern the different parts of the medication.

A short text, relevant enough to discern the different parts of the medication.

This is the only way for identifing the part to the medication. However it is not an absolute idenfication.

A code to indicate if the medication is in active use.

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

A coded concept defining if the medication is in active use.

No distinct manufacturer for each part of the medication

No distinct manufacturer for each part. Each part inherits the whole medication manufacturer.

Describes the form of the item. Powder; tablets; capsule.

This is the defined dose form of this part of the branded medication.

The dose form of the part is always defined and SHALL be provided.

Specific amount of the drug in the packaged product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.).

Identifies a particular constituent of interest in the product.

For the active ingedients, the medication contains ALL the ingredients and ONLY the ingredients.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

The actual substance or sub-part of the part of the branded medication.

Most of the few multi-part branded medication have a single level of parts with no sub-parts. For instance, a white tablet and a bue tablet. The item[x].refeence(FrMedicationUcdPart) is intende to describe the very few more complex multipart branded medications.

Support of french multi-part branded medication identfied by a code UDC.

Indication of whether this ingredient affects the therapeutic action of the drug.

True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive).

Specifies how much subtance of the item[x]:codeableConcept(snomedSubstance) or how many of the item[x]:refernce(FrMedciationUcdPart) there are in this FrMedicationUcdPart

The quantity of this ingredient defining the medication. For instance, 50 mg/mL defining the glucose quantity for the glucose 5% or 500 mg medicine and 30 mg respectively defining the paracetamol and the codeine quantity for the association paracetamol+codeine 500 mg+30 mg medicine.

This applies for the proprietary named medication involved in a MedicationDispense, MedicationAdministration or a MedicationUse.

WARNING: it is the batch number of the part. If it is not discerned for each part, it SHALL NOT be provided here but at the grouping level where it is defined, most often the UCD.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

The assigned lot number of a batch of the specified product.

When this specific batch of product will expire.